fbpx

A Vaccine Against Eye Cancer

Researchers are currently testing a vaccine that improves the chances of recovery of patients with ocular tumors by stimulating their immune response.

Choroidal melanoma is the most common ocular malignancy. If it is not treated quickly enough, metastases develop and can cause death. Researchers at the University Hospital of Erlangen, Germany, have developed a vaccine to prevent the development of metastases.

Dendritic cells typically trigger the immune response after recognizing a threat. However, in cancer patients, the tumor often blocks the immune response. The new vaccine contains custom dendritic cells and triggers the immune response, which delays or prevents the formation of metastases.

Right now, 200 German patients involved in the study of the vaccine.

 

Featured Posts

Optometry Giving Sight logo a turquoise eye with black icons in the shape of people for the iris

Optometry Giving Sight’s Grant Process Begins March 1

Optometry Giving Sight (OGS) will begin accepting pre-applications for its grant program that funds sustainable, optometry-based projects to end preventable blindness and vision impairment throughout the world.

Learn More

CSI Dry Eye Software Announces the Appointment of Trudi Charest as Chief Sales Officer

CSI Dry Eye Software, an emerging AI dry eye software company at the forefront of pioneering artificial intelligence in dry eye diagnostics and treatment recommendations, announces that it has appointed Trudi Charest as CSO – Chief Sales Officer.

Read more

SightGlass Vision Receives Breakthrough Device Designation from U.S. FDA

SightGlass Vision announced that the FDA has granted Breakthrough Device designation to its Diffusion Optics Technology™ (DOT™) spectacle lenses.

Read more

Vitamin A Supplements do not Improve Vision for Individuals with Retinitis Pigmentosa

A new study from Dr. Eric Pierce and Dr. Jason Comander at Mass Eye and Ear does not show any benefit to taking high-dose vitamin A supplements for people with retinitis pigmentosa (RP).

Read more

Custom Lamination Meets Unmatched Style

Featuring a modified round shape with subtly pointed, thoughtfully thickened upper corners, the Fysh F-3725 col. S412 acetate frame radiates sophistication while accentuating the distinctive contours of this eyewear masterpiece.

Read more
Optometry Giving Sight logo a turquoise eye with black icons in the shape of people for the iris

Optometry Giving Sight’s Grant Process Begins March 1

Optometry Giving Sight (OGS) will begin accepting pre-applications for its grant program that funds sustainable, optometry-based projects to end preventable blindness and vision impairment throughout the world.

Learn More

CSI Dry Eye Software Announces the Appointment of Trudi Charest as Chief Sales Officer

CSI Dry Eye Software, an emerging AI dry eye software company at the forefront of pioneering artificial intelligence in dry eye diagnostics and treatment recommendations, announces that it has appointed Trudi Charest as CSO – Chief Sales Officer.

Read More

SightGlass Vision Receives Breakthrough Device Designation from U.S. FDA

SightGlass Vision announced that the FDA has granted Breakthrough Device designation to its Diffusion Optics Technology™ (DOT™) spectacle lenses.

Read More

Vitamin A Supplements do not Improve Vision for Individuals with Retinitis Pigmentosa

A new study from Dr. Eric Pierce and Dr. Jason Comander at Mass Eye and Ear does not show any benefit to taking high-dose vitamin A supplements for people with retinitis pigmentosa (RP).

Read More

Custom Lamination Meets Unmatched Style

Featuring a modified round shape with subtly pointed, thoughtfully thickened upper corners, the Fysh F-3725 col. S412 acetate frame radiates sophistication while accentuating the distinctive contours of this eyewear masterpiece.

Read More
Optometry Giving Sight logo a turquoise eye with black icons in the shape of people for the iris

Optometry Giving Sight’s Grant Process Begins March 1

Optometry Giving Sight (OGS) will begin accepting pre-applications for its grant program that funds sustainable, optometry-based projects to end preventable blindness and vision impairment throughout the world.

Learn More

CSI Dry Eye Software Announces the Appointment of Trudi Charest as Chief Sales Officer

CSI Dry Eye Software, an emerging AI dry eye software company at the forefront of pioneering artificial intelligence in dry eye diagnostics and treatment recommendations, announces that it has appointed Trudi Charest as CSO – Chief Sales Officer.

Read more

SightGlass Vision Receives Breakthrough Device Designation from U.S. FDA

SightGlass Vision announced that the FDA has granted Breakthrough Device designation to its Diffusion Optics Technology™ (DOT™) spectacle lenses.

Read more

Vitamin A Supplements do not Improve Vision for Individuals with Retinitis Pigmentosa

A new study from Dr. Eric Pierce and Dr. Jason Comander at Mass Eye and Ear does not show any benefit to taking high-dose vitamin A supplements for people with retinitis pigmentosa (RP).

Read more

Custom Lamination Meets Unmatched Style

Featuring a modified round shape with subtly pointed, thoughtfully thickened upper corners, the Fysh F-3725 col. S412 acetate frame radiates sophistication while accentuating the distinctive contours of this eyewear masterpiece.

Read more
Optometry Giving Sight logo a turquoise eye with black icons in the shape of people for the iris

Optometry Giving Sight’s Grant Process Begins March 1

Optometry Giving Sight (OGS) will begin accepting pre-applications for its grant program that funds sustainable, optometry-based projects to end preventable blindness and vision impairment throughout the world.

Learn More

CSI Dry Eye Software Announces the Appointment of Trudi Charest as Chief Sales Officer

CSI Dry Eye Software, an emerging AI dry eye software company at the forefront of pioneering artificial intelligence in dry eye diagnostics and treatment recommendations, announces that it has appointed Trudi Charest as CSO – Chief Sales Officer.

Read more

SightGlass Vision Receives Breakthrough Device Designation from U.S. FDA

SightGlass Vision announced that the FDA has granted Breakthrough Device designation to its Diffusion Optics Technology™ (DOT™) spectacle lenses.

Read more

Vitamin A Supplements do not Improve Vision for Individuals with Retinitis Pigmentosa

A new study from Dr. Eric Pierce and Dr. Jason Comander at Mass Eye and Ear does not show any benefit to taking high-dose vitamin A supplements for people with retinitis pigmentosa (RP).

Read more

Custom Lamination Meets Unmatched Style

Featuring a modified round shape with subtly pointed, thoughtfully thickened upper corners, the Fysh F-3725 col. S412 acetate frame radiates sophistication while accentuating the distinctive contours of this eyewear masterpiece.

Read more